Pictured above: A scene from the accident that involved 9 vehicles

Last week, two accidents occurred that involved one careless truck driver. The first accident happened on Wednesday, June 24th in Wildwood, Florida when Benjamin Scott Brewer sideswiped a truck while he attempted to pass. Brewer bumped the other truck and both trucks pulled over.

Judge Joseph Goodwin, the federal judge in charge of overseeing multidistrict litigation involving transvaginal mesh and sling products, has moved to consolidate more than a dozen such lawsuits for jury trial this November. The decision came on June 12th, when he consolidated 26 transvaginal mesh lawsuits into a single trial which is set to begin

Xarelto, a relatively new prescription blood thinner, was first approved by the FDA in 2011 for patients who were at risk of developing blood clots as a result of knee or hip replacement surgeries. The marketers of the anticoagulant, Janssen Pharmaceuticals, aggressively marketed the drug as a "one-size-fits-all" drug. Given that, doctors readily prescribed the

In 2012, Reuters published a piece that touched on the hesitancy that some doctors felt about a new generation of blood thinners, one of which was Xarelto. In 2011, the FDA had approved Xarelto for prophylaxis of deep vein thrombosis (DVT) in patients undergoing hip or knee replacement surgeries. A few months later, in

Bayer, the manufacturer of the blockbuster anticoagulant drug, Xarelto, is not only facing a significant number of lawsuits within the United States, but also abroad in other countries. Recently, a number of Canadian citizens have filed claims against Bayer, either on their own behalf or that of deceased family members. According to Toronto lawyer Bryan

When Xarelto was first introduced to the general pharmaceutical company, it was touted as a much more convenient alternative to traditional blood thinners like warfarin. The drug was originally prescribed to patients who had undergone knee and hip replacement surgery and who were at a higher risk of blood clots following those procedures. The advantage,